Purpose: Current guideline recommendations for effective strategies to optimize the treatment of patients with concomitant hypertension and type 2 diabetes mellitus are reviewed. Summary ...

Similar to patients with type 2 diabetes mellitus, the great majority of all Americans, probably as much as 70% of the population, display an inability or unwillingness to meet the minimum ...

Discover how vitamin D may hold the key to managing type 2 diabetes with new insights into its impact on insulin and glucose ...

Alnylam is suspending further development of a clinical-stage RNAi therapeutic designed to treat Type 2 diabetes among ...

Each year, 1.4 million people are diagnosed with diabetes mellitus in the U.S., according to the association ... Here's what you need to know about the differences between Type 1 and Type 2 diabetes, ...

It is therefore important to study the effects of thiazolidinediones in larger and unselected populations of patients with type 2 diabetes. The aim of this study was to investigate whether ...

Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs.

The following is a summary of “Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study,” published in the October 2024 issue of Gastroenterology by ...

Vitamin D's role in type 2 diabetes management is evolving, with evidence suggesting it may improve blood sugar levels and reduce diabetes-related inflammation.

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes mellitus (T2DM) was not ...

Semaglutide was linked to a significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs.